{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:38:12Z","timestamp":1788910692707,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>Parkinson\u2019s disease (PD) causes major changes in dopaminergic neurons of the brain, resulting in motor symptoms in older adults. A previous study showed that Danshensu alleviates the cognitive decline by attenuating neuroinflammation. In the present study, we investigated the neuroprotective effect of Danshensu in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD. C57BL\/6 mice were randomly divided into the following four groups: control, MPTP, Danshensu at 15\u2009mg\/kg, and Danshensu at 60\u2009mg\/kg. The mice were administered Danshensu intragastrically for 14 days. In the behavioral tests, Danshensu treatment alleviated motor dysfunction induced by MPTP. The number of tyrosine hydroxylase-positive neurons in the substantia nigra was significantly reduced in the MPTP group, relative to the control group; Danshensu partially blocked this reduction in tyrosine hydroxylase-positive neurons. In addition, Danshensu attenuated the reductions in striatal dopamine and 5-HT levels induced by MPTP. Danshensu also diminished the increase in Iba1-positive cells in the substantia nigra and reduced the levels of interleukin-1\u03b2 and tumor necrosis factor-\u03b1 in the striatum. These findings suggest that Danshensu exerts neuroprotective effects and improves motor function in PD mice, at least in part, by reducing neuroinflammation.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000412","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T02:02:34Z","timestamp":1527732154000},"page":"36-44","source":"Crossref","is-referenced-by-count":14,"title":["Neuroprotective effects of Danshensu in Parkinson\u2019s disease mouse model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"],"prefix":"10.1097","volume":"30","author":[{"given":"Bing","family":"Han","sequence":"first","affiliation":[{"name":"Center for Mitochondria and Healthy Aging, School of Life Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Che","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), School of Pharmacy, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[{"name":"Center for Mitochondria and Healthy Aging, School of Life Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiting","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), School of Pharmacy, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"He","sequence":"additional","affiliation":[{"name":"Center for Mitochondria and Healthy Aging, School of Life Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[{"name":"Center for Mitochondria and Healthy Aging, School of Life Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Mitochondria and Healthy Aging, School of Life Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), School of Pharmacy, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.parkreldis.2009.05.005","article-title":"[11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson\u2019s disease?","volume":"16","author":"Bartels","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbr.2017.02.005","article-title":"Dissociation between dopaminergic response and motor behavior following intrastriatal, but not intravenous, transplant of bone marrow mononuclear stem cells in a mouse model of Parkinson\u2019s disease","volume":"324","author":"Calice da Silva","year":"2017","journal-title":"Behav Brain Res"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-016-0063-3","article-title":"The biomarkers of immune dysregulation and inflammation response in Parkinson disease","volume":"5","author":"Chen","year":"2016","journal-title":"Transl Neurodegener"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2013.02.069","article-title":"Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish","volume":"543","author":"Chong","year":"2013","journal-title":"Neurosci Lett"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","article-title":"Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging","volume":"15","author":"Cicchetti","year":"2002","journal-title":"Eur J Neurosci"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2014.10.028","article-title":"Inflammation is genetically implicated in Parkinson\u2019s disease","volume":"302","author":"Dzamko","year":"2015","journal-title":"Neuroscience"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.phymed.2014.12.001","article-title":"Neuroprotective effect and underlying mechanism of sodium danshensu [3-(3,4-dihydroxyphenyl) lactic acid from Radix and Rhizoma Salviae miltiorrhizae=Danshen] against cerebral ischemia and reperfusion injury in rats","volume":"22","author":"Guo","year":"2015","journal-title":"Phytomedicine"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11064-009-0035-4","article-title":"Effects of hydroxysafflor yellow A in the attenuation of MPTP neurotoxicity in mice","volume":"35","author":"Han","year":"2010","journal-title":"Neurochem Res"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/mt.2010.217","article-title":"Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson\u2019s disease","volume":"19","author":"Harms","year":"2011","journal-title":"Mol Ther"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnana.2015.00032","article-title":"Inflammation in Parkinson\u2019s disease: role of glucocorticoids","volume":"9","author":"Herrero","year":"2015","journal-title":"Front Neuroanat"},{"key":"R11-20230910","first-page":"120","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson\u2019s disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fncel.2013.00053","article-title":"Interleukin-1\u03b2 and tumor necrosis factor-\u03b1: reliable targets for protective therapies in Parkinson\u2019s disease?","volume":"7","author":"Leal","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejphar.2016.11.050","article-title":"D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson\u2019s disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation","volume":"797","author":"Li","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1179\/1476830515Y.0000000010","article-title":"Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress","volume":"19","author":"Nataraj","year":"2016","journal-title":"Nutr Neurosci"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuroscience.2014.07.046","article-title":"Neuroprotective effect of metformin in MPTP-induced Parkinson\u2019s disease in mice","volume":"277","author":"Patil","year":"2014","journal-title":"Neuroscience"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-gamma agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson\u2019s disease","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiol Dis"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/ene.12950","article-title":"The impact of non-motor symptoms on the quality of life of Parkinson\u2019s disease patients: a longitudinal study","volume":"23","author":"Prakash","year":"2016","journal-title":"Eur J Neurol"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2015.05.024","article-title":"Neuroprotective effect of lycopene against MPTP induced experimental Parkinson\u2019s disease in mice","volume":"599","author":"Prema","year":"2015","journal-title":"Neurosci Lett"},{"key":"R21-20230910","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuropharm.2015.01.030","article-title":"Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice","volume":"93","author":"Ren","year":"2015","journal-title":"Neuropharmacology"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","article-title":"A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death","volume":"137","author":"Saijo","year":"2009","journal-title":"Cell"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory mechanisms in Parkinson\u2019s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention","volume":"208","author":"Tansey","year":"2007","journal-title":"Exp Neurol"},{"key":"R24-20230910","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2008.07.015","article-title":"Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury","volume":"32","author":"Vuckovic","year":"2008","journal-title":"Neurobiol Dis"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jneuroim.2012.02.008","article-title":"Danshensu ameliorates the cognitive decline in streptozotocin-induced diabetic mice by attenuating advanced glycation end product-mediated neuroinflammation","volume":"245","author":"Wang","year":"2012","journal-title":"J Neuroimmunol"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201902000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:06:06Z","timestamp":1694333166000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201902000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000412","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}